Katharina Pomej

11PUBLICATIONS
61CO-AUTHORS
Cardiology (incl. cardiovascular diseases)ChemotherapyCancer therapy (excl. chemotherapy and radiation therapy)Cell physiologyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 01, 2026
Summative Comorbidities Are Independently Associated With Mortality in Patients With Hepatocellular Carcinoma.

|May 12, 2025
Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis.

Stefan Munker, Isaac Rodriguez, Kathrin Bernhart

|Apr 15, 2025
Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study.

Katharina Pomej, Adrian Frick, Bernhard Scheiner

|Jul 11, 2024
Evolution of liver function during immune checkpoint inhibitor treatment for hepatocellular carcinoma.

Katharina Pomej, Lorenz Balcar, Sabrina Sidali

|Sep 14, 2023
Transversal psoas muscle thickness measurement is associated with response and survival in patients with HCC undergoing immunotherapy.

Bernhard Scheiner, Katharina Lampichler, Katharina Pomej

|Dec 08, 2021
Antibiotic Therapy is Associated with Worse Outcome in Patients with Hepatocellular Carcinoma Treated with Sorafenib.

Katharina Pomej, Lorenz Balcar, Bernhard Scheiner

Pageof 2

Frequent Collaborators

8 joint publications

Lorenz Balcar

6 joint publications

Bernhard Scheiner

6 joint publications

Thomas Reiberger

6 joint publications

Matthias Pinter